mesohyal^®

hydration, elasticity, firmness, and tissue quality. The products are CE‑marked for intradermal administration and are used in both facial and body protocols. The range supports personalised treatment planning, allowing practitioners to tailor sessions based on patient needs and clinical objectives. mesohyal® can be administered manually with Luer‑Lock syringes or via multi‑injection devices, targeting the superficial dermis. Sessions typically last 20–30 minutes, with recommended treatment cycles of five facial sessions or ten body sessions. The system is used to address wrinkles, sagging, dehydration, and age‑related changes in skin quality.